Autoimmune

Researchers have identified a way of selectively eliminating the ‘bad’ immune cells that contribute to autoimmune skin diseases like psoriasis while leaving the ‘good’ cells intact. The discovery could lead to longer-lasting, more targeted treatments.

An ‘inverse vaccine’ has been developed that reverses the damage caused when the immune system mistakenly attacks the body’s healthy organs and tissues. It could pave the way to a treatment for autoimmune diseases like MS, type 1 diabetes and arthritis.

Scientists have demonstrated in mice that specially designed probiotics can reduce brain inflammation from diseases like multiple sclerosis. The study points to new potential therapies for chronic conditions that may be as simple as popping a pill.

Multiple sclerosis sufferers can experience long periods of remission, but increasingly damaged nerves make relapses more frequent and severe. Scientists now believe, with a little molecular encouragement, those damaged nerves can heal themselves.

Researchers have discovered new information about how the body’s antibody-mediated immune system works, calling into question long-held scientific understanding and opening the door for potential advancements in immunological treatment.

Autoimmune diseases such as MS and rheumatoid arthritis affect almost four percent of the global population. A new study has now identified a naturally occurring compound that may provide a new way of treating these debilitating diseases.

Investigating ways to head off the chain of events that leads to multiple sclerosis, researchers have found a chemical regulator in mice that causes the inflammatory cascade associated with the disease. They also figured out how to switch it off.

Immune suppression can help relieve symptoms of autoimmune diseases, but it can cause complications. A new nanoparticle therapy selectively targets problematic immune cells, and was able to significantly delay and even prevent arthritis in mice.

Our immune system can unfortunately go rogue and attack healthy tissues. Scientists at Johns Hopkins University have now engineered a protein that may help prevent these autoimmune diseases by boosting the number of regulatory T cells (Tregs).

Scientists have reported that five patients undergoing an experimental treatment for lupus have all entered remission for up to 17 months. The promising breakthrough came from the use of CAR T cell immunotherapy, increasingly used to treat cancer.

The FDA has followed highly promising results from trials demonstrating the hair regrowth potential of a common arthritis drug with a landmark approval, giving baricitinib the green light as a treatment for severe alopecia areata.

Scientists may have uncovered a new therapy for multiple sclerosis, involving an inflammation-regulating lipid. Tests in mice showed that the lipid reduced symptoms and slowed disease progression, hinting at an underlying mechanism for the condition.